Weight Loss In Women

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk's reach is limited

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent expiries such as that of semaglutide in 2026

As the use of weight-loss injections rises, users report effects like Ozempic face, tongue, and teeth- here is what these mean and how to manage them

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping- experts explain why it happens, who's at risk, and how to keep the weight off

The Danish drugmaker's arch-rival Eli Lilly & Co. has introduced another shot - Zepbound, also known as Mounjaro - that so far has shown even more weight loss than Wegovy

This somewhat frustrating outcome does not mean that exercise is not good for people